Not Yet Recruiting
Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma
NCT07515625
- Conditions
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
Not specified